Cost-minimisation analysis of oritavancin for the treatment of acute bacterial skin and skin structure infections from a United Kingdom perspective.
Saved in:
| Title: | Cost-minimisation analysis of oritavancin for the treatment of acute bacterial skin and skin structure infections from a United Kingdom perspective. |
|---|---|
| Authors: | Zinzi D; Menarini Ricerche Spa, Florence, Italy., Vlachaki I; Menarini Ricerche Spa, Florence, Italy., Falla E; EMEA Real World Methods and Evidence Generation, IQVIA Ltd, London, UK., Mantopoulos T; EMEA Real World Methods and Evidence Generation, IQVIA Ltd, Athens, Greece. tmantopoulos@gr.imshealth.com., Nathwani D; Medical School, University of Dundee, Dundee, DD19SY, UK. |
| Source: | The European journal of health economics : HEPAC : health economics in prevention and care [Eur J Health Econ] 2022 Nov; Vol. 23 (8), pp. 1371-1381. Date of Electronic Publication: 2022 Feb 03. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 101134867 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1618-7601 (Electronic) Linking ISSN: 16187598 NLM ISO Abbreviation: Eur J Health Econ Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1618-7601 |
|---|---|
| DOI: | 10.1007/s10198-022-01432-2 |
